Table 1.
Clinicopathologic characteristics of 100 mucinous rectal cancer patients.
| Variable | Value |
|---|---|
| Median age (range), y | 60.5 (26–81) |
| Gender, n | |
| Male | 70 |
| Female | 30 |
| Tumor size, cm | |
| ≥5 | 9 |
| <5 | 91 |
| T stage, n | |
| T3 | 58 |
| T4 | 42 |
| Lymph node involvement, n | |
| N(−) | 19 |
| N(+) | 81 |
| Stage, n | |
| II | 18 |
| III | 82 |
| Interval from CCRT to operation (wk) | |
| <7 | 64 |
| ≥7 | 36 |
| Total dose of radiotherapy (Gy) | |
| <50 | 23 |
| ≥50 | 77 |
| Chemotherapy regimens | |
| Capecitabine | 30 |
| L-OHP+ capecitabine | 65 |
| CPT-11+capecitabine | 5 |
| Initial HB | |
| <10 | 8 |
| ≥10 | 92 |
| Preoperative CEA levels | |
| Mean (range), U/ml | 10 (0.48–184) |
| Preoperative AFP levels | |
| Mean (range), U/ml | 3.75 (1.05–22.2) |
| Lymphovascular invasion, n | |
| Positive | 12 |
| Negative | 88 |
| Perineural invasion, n | |
| Positive | 14 |
| Negative | 86 |